Tumor Biology

SAGE Publishing

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Tumor Biology is an open-access journal published by SAGE Publishing in United Kingdom, publishing in english. It is listed in DOAJ and MEDLINE and PUBMED according to the sources read. Declared publication charge: 2,100 USD. Declared review time at DOAJ: 15 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
SAGE Publishing
ISSN
1010-4283 · 1423-0380
Country
United Kingdom
Languages
english
Access
Open access
Declared publication charge
2,100 USD
Articles in DOAJ
863
Declared review time
15 weeks
Declared peer-review model
peer_review

Index listings

  • DOAJ · 2018-08-03
  • MEDLINE · 1984-01-01
  • PUBMED · 2015-06-25
Indexing
DOAJ · MEDLINE · PUBMED
APC
2,100 USD
Declared review time (DOAJ)
15 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

863

Most recent article

2 months ago

Average review time (journal-declared via DOAJ)

15weeks

Works in OpenAlex

8704

Last recorded publication year

2026

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

122

i10-index

5632

From OpenAlex open data (CC0).

Editorial & policy12
Last DOAJ review date
2025-06-11
Added to DOAJ
2018-08-03
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
CLOCKSS
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Editorial board
Official page ↗
Open references deposited at Crossref
82%
ORCID iDs in current deposits
50%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity3
Source type
journal
NLM unique ID (PubMed)
8409922
Classification2

Subjects (DOAJ)

Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens

LCC codes

RC254-282

Subject areas

  • Cancer-related molecular mechanisms research
  • Cancer-related molecular mechanisms research
  • MicroRNA in disease regulation
  • MicroRNA in disease regulation
  • RNA modifications and cancer
  • RNA modifications and cancer
  • Circular RNAs in diseases
  • Circular RNAs in diseases
Show all subjects (50)
  • Cancer Cells and Metastasis
  • Cancer Cells and Metastasis
  • Epigenetics and DNA Methylation
  • Epigenetics and DNA Methylation
  • Cancer, Hypoxia, and Metabolism
  • Cancer, Hypoxia, and Metabolism
  • Cancer-related Molecular Pathways
  • Cancer-related Molecular Pathways
  • Peptidase Inhibition and Analysis
  • Peptidase Inhibition and Analysis
  • Cancer-related gene regulation
  • Cancer-related gene regulation
  • RNA Research and Splicing
  • RNA Research and Splicing
  • Cancer Genomics and Diagnostics
  • Cancer Genomics and Diagnostics
  • Glycosylation and Glycoproteins Research
  • Glycosylation and Glycoproteins Research
  • Cancer Research and Treatments
  • Cancer Research and Treatments
  • Genetic factors in colorectal cancer
  • Genetic factors in colorectal cancer
  • Pancreatic and Hepatic Oncology Research
  • Pancreatic and Hepatic Oncology Research
  • Immunotherapy and Immune Responses
  • Immunotherapy and Immune Responses
  • Cancer, Lipids, and Metabolism
  • Cancer, Lipids, and Metabolism
  • Monoclonal and Polyclonal Antibodies Research
  • Monoclonal and Polyclonal Antibodies Research
  • Cancer Mechanisms and Therapy
  • Cancer Mechanisms and Therapy
  • DNA Repair Mechanisms
  • DNA Repair Mechanisms
  • Lung Cancer Treatments and Mutations
  • Lung Cancer Treatments and Mutations
  • Lung Cancer Research Studies
  • Lung Cancer Research Studies
  • Cell Adhesion Molecules Research
  • Cell Adhesion Molecules Research
  • Cancer Immunotherapy and Biomarkers
  • Cancer Immunotherapy and Biomarkers

Keywords (DOAJ)

  • molecular biomarkers
  • tumour markers
  • tumour targetting

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: